About Dr. Burton Berkson


Roosevelt University BS Biology 1962

Eastern Illinois University MS Biology1964
(thesis on the cell biology of fungi) Published in Mycologia

University of Illinois PhD Biology 1968
(thesis cyto-morpho-biology of selected fungi) Published in Cytologia and The American Journal of Botany


Universidad Autonoma, CJ, Chih. Mexico MD 1977, PhD to MD program
Internal medicine residency year one (PG 1), St Luke’s Hospital (Case Western Reserve teaching hospital), Cleveland 1977
Pathology residency year two (PG 2), Mount Sinai Hospital (Case Western Reserve teaching hospital), Cleveland 1978

Assistant professor, Rutgers University 1968-1972
Associate professor, Chicago State University 1972-1974
Instructor, Medical Microbiology, Universidad Autonoma, CJ,Chih. Mexico  MD 1975-1976
Instructor, Huron Road teaching hospital, Cleveland 1976
Research Associate, Cleveland Museum of Natural History, Cleveland, 1977-1979
Private Practice, Lovington, New Mexico 1979-1986
Private ER doctor, 1986-1988
Medical Director, Hunter Clinic, Wichita, Kansas 1988-1989
Attending Physician, White Sands Missile Range and Research Facility, Department of Defense, White Sands, New Mexico1989-1997
Private Practice, President of the Integrative Medical Center of New Mexico, Las Cruces, New Mexico, 1997-Present

Invited Lecturer, Low Dose Naltrexone Conference, Dublin, Ireland September, 2011.
Invited Visiting Professor, The Japanese College of Intravenous Therapy, Tokyo, Japan  2010.
Invited Visiting Lecturer, Glasgow University College of Medicine, Glasgow, Scotland 2009.
Invited Lecturer, 5th Annual LDN Conference, National Institutes of Health, Bethesda, Maryland 2009.
Invitational Presentation Experiences with LDN AND ALPHA LIPOIC ACID for cancer and autoimmune diseases A Revolution in Research The Fourth Annual LDN Conference, October 11, 2008 — University of Southern California Health Sciences Campus Los Angeles, California
Invitational Lectures Integrative Approaches to the management of Acute and Chronic Liver Disease and Cancer, American College for the  Advanmcement of Medicine  2007
Invitational Lecture, Low Dose Naltrexone Group,  Vanderbilt University Nashville 2007
Invitational Presentation,  National Cancer Institute, on Low Dose Naltrexone and Cancer and Autoimmune Disease National Cancer Institute Bethesda, 2007
Invitational Presentation, American Holistic Medical Association, Clinical and Scientific Conference Alphic Lipoic Acid as a Potential Therapy for Liver Disease  Philadelphia 2005
Invitational Presentation, Institute of Functional Medicine Conference, Palm Springs 2005 The Management of Autoimmune liver disease
Invitational Presentation, University of Illinois Masonic Hospital 2005 Practical Approaches to the Treatment of Acute and Chronic Liver Disease using Alpha Lipoic Acid
Invited Lecturer, Diabetes and Alcoholism American Indian Conference, Tulsa, Oklahoma 2001
Invited Visiting Scientist and Lecturer, Max Planck Institute, Heidelberg, Germany, 1978
National Science Foundation Traineeship, University of Illinois 1960’s
United States FDA principal Investigator intravenous Alpha Lipoic Acid for 23 years
CDC expert, intravenous Alpha Lipoic Acid and hepatotoxic poisoning, Centers for Disease Control and Prevention, 1990-present
Numerous scientific articles, books, and invited lectures and workshops